It is a broadly described annual report of Dr. Reddy’s Laboratories Limited in the year of 2013-2014. During the financial year, The Company’s revenue was Rs. 132.2 billion up 13.7% over the previous year. In US$ terms, this amounted to US$ 2.20 billion. Earnings before interest, taxes, depreciation, and amortization (EBITDA) grew by 19.3% to Rs. 33.2 billion, amounting to 25% of consolidated revenue. Profit before taxes (PBT) was Rs. 26.6 billion which was a growth of 22.7% over the previous year. In US$ terms, it was US$ 443 million. Profits after tax (PAT) was Rs. 21.5 billion an increase of 28.2% over the previous year and was at 16% of consolidated revenue. The paid-up share capital of the Company increased by Rs. 1.36 million in FY2014.
The Board of Directors is pleased to recommend a dividend of Rs. 18 on every equity share of Rs. 5/- each (360%) for FY2014.
More Annual Report of Dr. Reddy’s Laboratories Limited:
- Annual Report 2001-2002 of Dr. Reddy’s Laboratories Limited
- Annual Report 2002-2003 of Dr. Reddy’s Laboratories Limited
- Annual Report 2003-2004 of Dr. Reddy’s Laboratories Limited
- Annual Report 2004-2005 of Dr. Reddy’s Laboratories Limited
- Annual Report 2005-2006 of Dr. Reddy’s Laboratories Limited
- Annual Report 2006-2007 of Dr. Reddy’s Laboratories Limited
- Annual Report 2007-2008 of Dr. Reddy’s Laboratories Limited
- Annual Report 2008-2009 of Dr. Reddy’s Laboratories Limited
- Annual Report 2009-2010 of Dr. Reddy’s Laboratories Limited
- Annual Report 2010-2011 of Dr. Reddy’s Laboratories Limited
- Annual Report 2011-2012 of Dr. Reddy’s Laboratories Limited
- Annual Report 2012-2013 of Dr. Reddy’s Laboratories Limited
- Annual Report 2013-2014 of Dr. Reddy’s Laboratories Limited
- Annual Report 2014-2015 of Dr. Reddy’s Laboratories Limited
- Annual Report 2015-2016 of Dr. Reddy’s Laboratories Limited
- Annual Report 2016-2017 of Dr. Reddy’s Laboratories Limited
